parkinson disease
Showing NaN - NaN of 47
Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in United States (Non-invasive brainstem stimulation)
Recruiting
- Parkinson Disease
- Parkinson's Disease and Parkinsonism
- Non-invasive brainstem stimulation
-
Scottsdale, Arizona
- +18 more
Jan 26, 2023
Parkinson Disease, Healthy Participants Trial in United States (TAK-071, Placebo)
Active, not recruiting
- Parkinson Disease
- Healthy Participants
- TAK-071
- Placebo
-
Garden Grove, California
- +20 more
Nov 30, 2022
Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in United States (Open Label Extension Study)
Enrolling by invitation
- Parkinson Disease
- Parkinson's Disease and Parkinsonism
- Open Label Extension Study
-
Scottsdale, Arizona
- +14 more
Oct 24, 2022
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort
Recruiting
- Parkinson Disease
-
Birmingham, Alabama
- +50 more
Jul 26, 2022
Parkinson Disease Trial in Worldwide (Omnidirectional stimulation, Directional stimulation)
Completed
- Parkinson Disease
- Omnidirectional stimulation
- Directional stimulation
-
Sacramento, California
- +48 more
Jun 28, 2022
Parkinson Disease Trial in New York, Houston (Spinal Cord Stimulator (SCS))
Recruiting
- Parkinson Disease
- Spinal Cord Stimulator (SCS)
-
New York, New York
- +1 more
Apr 18, 2022
Parkinson Disease Trial in Worldwide (IPX203 140 mg, IPX203 210 mg, IPX203 280 mg)
Completed
- Parkinson Disease
- IPX203 140 mg
- +3 more
-
Phoenix, Arizona
- +97 more
Apr 5, 2022
Constipation, Parkinson Disease Trial in United States (Active Investigational Treatment ENT-01, Placebo Treatment)
Completed
- Constipation
- Parkinson Disease
- Active Investigational Treatment ENT-01
- Placebo Treatment
-
Sun City, Arizona
- +50 more
Mar 21, 2022
Wearable Assessments in the Clinic and Home in PD
Active, not recruiting
- Parkinson Disease
-
Sun City, Arizona
- +16 more
Mar 9, 2022
Parkinson Disease Trial in United States (Personal KinetiGraph® (PKG®) Watch, Personal KinetiGraph® (PKG®) Report)
Terminated
- Parkinson Disease
- Personal KinetiGraph® (PKG®) Watch
- Personal KinetiGraph® (PKG®) Report
-
Fayetteville, Arkansas
- +16 more
Jan 12, 2022
Parkinson Disease Trial in United States (SAGE-217, Levodopa, Antiparkinsonian Agent(s))
Parkinson Disease Trial in Houston (PRIM-DJ2727, Placebo oral capsule)
Active, not recruiting
- Parkinson Disease
- PRIM-DJ2727
- Placebo oral capsule
-
Houston, TexasThe University of Texas Health Science Center at Houston
Dec 23, 2021
Parkinson Disease Trial in Worldwide (THN102 Dosage A, THN102 Dosage B, THN102 Dosage C)
Completed
- Parkinson Disease
- THN102 Dosage A
- +2 more
-
Kansas City, Kansas
- +33 more
Nov 27, 2020
Parkinson Disease Trial in United States (Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), Cohort 2: Nilotinib Oral Capsules
Completed
- Parkinson Disease
- Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)
- +2 more
-
Birmingham, Alabama
- +23 more
Jul 21, 2020
Parkinson Disease Trial in United States (Personal KinetiGraph™ (PKG™))
Active, not recruiting
- Parkinson Disease
- Personal KinetiGraph™ (PKG™)
-
Sacramento, California
- +11 more
Mar 3, 2020
Parkinson Disease Trial in Canada, United States (Isradipine, Placebo (for Isradipine))
Completed
- Parkinson Disease
- Isradipine
- Placebo (for Isradipine)
-
Birmingham, Alabama
- +53 more
Jan 7, 2020
Parkinson Disease Trial in Houston (Smartphone-based balance exercises)
Unknown status
- Parkinson Disease
- Smartphone-based balance exercises
-
Houston, TexasCenter for Neuromotor and Biomechanics Research
Oct 28, 2019